Prostate cancer |
Increase cancer stem cell phenotype |
|
Melanoma |
Tumorigenic |
Antiangiogenic or induction of MDSCs |
Colorectal cancer |
Tumorigenic |
immune‐independent mediated antitumor effect |
Bladder carcinoma |
Autocrine growth |
|
Glioma |
Angiogenic, induction of MDSCs, autocrine/paracrine growth |
|
Lung cancer |
Angiogenic, induction of MDSCs |
|
Hepatocellular carcinoma |
Accumulation of MDSCs, splenic EMH |
Accumulation of MDSCs, splenic EMH |
Acute myeloid leukemia |
Proliferation of leukemia cells or provide better chemotherapy response |
Proliferation of leukemia cells or neutrophils recovery |